Measurement of heparin concentration in whole blood with the Hepcon/HMS device does not agree with laboratory determination of plasma heparin concentration using a chromogenic substrate for activated factor X
- 31 July 1996
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 112 (1) , 154-161
- https://doi.org/10.1016/s0022-5223(96)70191-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operationsThe Journal of Thoracic and Cardiovascular Surgery, 1995
- The impact of heparin concentration and activated clotting time monitoring on blood conservationThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Heparin and antithrombin III levels during cardiopulmonary bypass: Correlation with subclinical plasma coagulationThe Annals of Thoracic Surgery, 1994
- The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgeryTransfusion, 1994
- Heparin Management Protocol for Cardiopulmonary BypassAnesthesiology, 1992
- Comparing Methods of Measurement: An Alternative ApproachAnesthesiology, 1990
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Hemostasis Changes During Cardiopulmonary Bypass SurgerySeminars in Thrombosis and Hemostasis, 1985
- Monitoring Heparin Anticoagulation and Its NeutralizationThe Annals of Thoracic Surgery, 1981
- Platelet Aggregation Following Heparin and Protamine AdministrationAnesthesiology, 1978